Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 1087 results found. Search for [ Drug firm ]

Results 1 to 21 of 1087
Reuters
December 4, 2019
Trader groups have protested for years against e-pharmacies, saying they challenge their businesses and could allow medicines to be abused by being sold without proper verification


BusinessToday.In
December 3, 2019
Ogivri will be launched at a competitive discount for customers to help ensure increased access to treatment for thousands of HER2-positive breast and gastric cancer patients, said Biocon


BusinessToday.In
November 29, 2019
Aurobindo Pharma share price gained 2.67% to Rs 462.2 compared to the previous close of Rs 450.20 on BSE


Joe C Mathew
November 28, 2019
Diagnostic imaging sector, largely dominated by big players, constitutes 36 per cent of the market, consumables and patient aids could be another 28 per cent, Invest India estimates


PB Jayakumar
November 26, 2019
TSSIA is meeting tomorrow to decide the future course of action, which includes a meeting of all Gramapanchayath heads and other authorities and the possibility of legal remedies: Ninad Jaywant


E Kumar Sharma
New Delhi, November 25, 2019
A number of biologics with huge markets are going off-patent in the US. Do Indian pharmaceutical companies have it in them to play this high-cost, high-risk game of launching biosimilars?


BusinessToday.In
November 21, 2019
Cadila Healthcare share price has lost 29% in one year and fallen 27% since the beginning of this year


PTI
November 18, 2019
The significant violations included failure to have adequate written procedures for the receipt, identification, testing and handling of raw materials


PB Jayakumar
New Delhi, November 12, 2019
The divestment will curtail 13 per cent global revenues of Lupin, which had posted Rs 16,369 crore consolidated revenues for the financial year ended March 31, 2019


PB Jayakumar
New Delhi, November 7, 2019
Lupin's net sales for the quarter stood at Rs 4,296 crore, an increase of 10.4 per cent compared to Rs 3,890 crore in the Q2FY19. The company posted a net loss of Rs 127 crore (after exceptional items) in Q2FY20, compared to Rs 266 crore net profit during the same quarter of the previous year


BusinessToday.In
New Delhi, November 6, 2019
Lupin Q2 results: Consolidated revenue from operations of the pharma major increased 10.3 per cent year-on-year (YoY) to Rs 4,359.7 crore in Q2FY20 as against Rs 3,951 crore in Q2FY19


BusinessToday.In
November 5, 2019
After hitting intra day high of Rs 263.70, Biocon stock saw profit-booking and fell 3.11% to Rs 355 on BSE


BusinessToday.In
November 4, 2019
Cadila Healthcare share which opened at Rs 257 against previous close of Rs 255.30 hit an intra day high of Rs 260.6 (2.08%)


BusinessToday.In
November 4, 2019
HDFC Q2 results: The total revenue from operations increased by 10.35 per cent to Rs 10,478.33 crore in Q2FY20 from Rs 9,494.70 crore in Q2FY19


BusinessToday.In
November 4, 2019
Hikal share price gained up to 9.51% to Rs 131.90 compared to the previous close of Rs 120.45 on BSE


PTI
October 31, 2019



PB Jayakumar
New Delhi, October 30, 2019
Robots are changing the world of surgery, including in India


Manu Kaushik
New Delhi, October 30, 2019
Even though Gangwal stands on thin ice if the powers entrusted in the shareholders' agreement are considered; Bhatia has much more to lose if this matter escalates further


PTI
October 30, 2019



PTI
October 28, 2019



PAGES 1 OF 55  12345